Skip to main content
Figure 2 | BMC Gastroenterology

Figure 2

From: Senescence marker protein 30 in acute liver failure: validation of a mass spectrometry proteomics assay

Figure 2

WB analysis of liver tissue SMP30 levels in GalN/LPS-treated mice. Lane 1: 5 h after saline injection; lane 2: 5 h after LPS injection; lane 3: 5 h after GalN injection; lane 4: 5 h after GalN/LPS injection; lane 5: 24 h after saline injection; lane 6: 24 h after LPS injection; lane 7: 24 h after GalN injection; lane 8: 24 h after GalN/LPS injection. SMP30 levels were significantly reduced in the liver tissues of mice treated with GalN/LPS compared with those of the control groups (P < 0.01). There was no significant difference between the SMP30 protein levels of groups 4 and 8 (P > 0.05).

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us